Rubicon Research IPO Day 3 LIVE: GMP, Subscription Status, Review — Should You Apply?
Rubicon Research IPO Day 3: Strong demand with 7.16x subscription and ₹110 GMP. Analysts recommend a ‘Subscribe’ rating. Know details, review, and listing date.
Rubicon Research IPO Day 3 Live: GMP at ₹110, Subscription 7.16x — Apply or Skip?
The final day of bidding for Rubicon Research Ltd’s IPO is underway today, October 13, 2025. The issue, which opened on October 9, has witnessed strong investor interest across all categories. The company has set a price band of ₹461–₹485 per share, aiming to raise ₹1,377.50 crore through a mix of fresh issue and offer for sale.
Rubicon Research IPO GMP Today
According to market observers, Rubicon Research shares are trading at a premium of ₹110 in the grey market. This indicates a strong grey market premium (GMP) and reflects robust investor sentiment backed by healthy subscription numbers and improved market conditions on Dalal Street.
Rubicon Research IPO Subscription Status
By 11:15 AM on Day 3, the IPO had been subscribed 7.16 times overall, with each investor category showing solid participation:
- Retail Investors: 10.66 times
- Non-Institutional Investors (NII): 14.79 times
- Qualified Institutional Buyers (QIB): 2.19 times
The strong subscription momentum signals widespread confidence in the company’s business model and growth prospects.
Rubicon Research IPO Review
Brokerages have largely maintained a “Subscribe” rating for the Rubicon Research IPO, citing its niche presence and strong fundamentals.
- Arihant Capital: “At the upper price band of ₹485, the issue is valued at a P/E of ~60x based on FY25 annualised EPS of ₹8.2. Given its focus on R&D and stable growth in the US generics market, we recommend a Subscribe rating.”
- Kunvarji Finstock: “We recommend subscribing to the IPO with a medium to long-term view. Rubicon’s focus on specialised generic products and strong financial performance are positives, though investors should monitor global trade policy changes closely.”
Rubicon Research IPO Key Details
- IPO Price Band: ₹461–₹485 per share
- Issue Size: ₹1,377.50 crore (Fresh Issue + OFS)
- Subscription (till 11:15 AM, Day 3): 7.16x overall
- Expected Allotment Date: October 14, 2025
- Likely Listing Date: October 16, 2025
- Listing Exchanges: BSE and NSE
Should You Apply?
According to analysts, Rubicon Research holds a long-term potential because of its R&D capabilities, niche market positioning, and good financial trajectory. Short-term investors are, however, urged to bear the questions of valuation and sectoral volatility in mind.
